These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32405964)

  • 1. Feasibility of implementing a cervix cancer-specific patient-reported outcome measure in routine ambulatory clinics.
    Atallah S; Barbera L; Folwell M; Howell D; Liu Z; Croke J
    Support Care Cancer; 2021 Jan; 29(1):499-507. PubMed ID: 32405964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H; Rajapaksa LC; Greimel ER
    Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer.
    Paradowska D; Tomaszewski KA; Bałajewicz-Nowak M; Bereza K; Tomaszewska IM; Paradowski J; Pityński K; Skotnicki P; Greimel ER; Bottomley A
    Eur J Cancer Care (Engl); 2014 Mar; 23(2):214-20. PubMed ID: 23957381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' acceptance and psychometric properties of the EORTC QLQ-CX24 after surgery.
    Singer S; Kuhnt S; Momenghalibaf A; Stuhr C; Dimmel-Hennersdorf U; Köhler U; Einenkel J
    Gynecol Oncol; 2010 Jan; 116(1):82-7. PubMed ID: 19836828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the psychometric properties of the translated versions of the European Organisation for the Research and Treatment of Cancer QLQ CX24 questionnaire in the two South African indigenous languages of Xhosa and Afrikaans.
    du Toit GC; Kidd M
    Eur J Cancer Care (Engl); 2016 Sep; 25(5):832-8. PubMed ID: 26052872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Czech version of EORTC QLQ-CX24 questionnaire for patients with cervical cancer].
    Halaška MJ; Brtnický T; Novácková M; Pluta M; Stankušová H; Chmel R; Hrehorcák M; Robová H; Rob L
    Ceska Gynekol; 2010 Dec; 75(6):529-34. PubMed ID: 27534010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
    Luvián-Morales J; Flores-Cisneros L; Jiménez-Lima R; Alarcón-Barrios S; Salazar-Mendoza J; Castro-Eguiluz D; Cetina-Pérez L; Oñate-Ocaña LF
    Int J Gynecol Cancer; 2021 Sep; 31(9):1228-1235. PubMed ID: 34353855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical results and patient-reported outcome measures.
    Alfrink J; Aigner T; Zoche H; Distel L; Grabenbauer GG
    Strahlenther Onkol; 2024 Aug; 200(8):706-714. PubMed ID: 38296845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
    Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
    Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Quality of Life and Sexuality between Cervical Cancer Survivors and Healthy Women.
    Lee Y; Lim MC; Kim SI; Joo J; Lee DO; Park SY
    Cancer Res Treat; 2016 Oct; 48(4):1321-1329. PubMed ID: 26875196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S; Jayasekara P; Abeysinghe P; Hjermstad M; Lalloo R
    BMC Oral Health; 2022 Aug; 22(1):359. PubMed ID: 35986341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
    Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
    Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer.
    Hua CH; Guo HM; Guan XL; Kong FJ; Hou RJ; Zhang XY; Li SR
    Patient Prefer Adherence; 2013; 7():1061-6. PubMed ID: 24204125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
    Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
    Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the Melanoma Concerns Questionnaire (MCQ-28); refinement of the EORTC QLQ-MEL38 module.
    Winstanley J; White E; Saw R; Young T; Burmeister B; Nikolic D; Busto-Cornide I; Iglesias-Pena N; Boyle F
    Psychooncology; 2020 Feb; 29(2):321-330. PubMed ID: 31652387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26.
    Arraras JI; Giesinger J; Shamieh O; Bahar I; Koller M; Bredart A; Costantini A; Greimel E; Sztankay M; Wintner LM; de Sousa MC; Ishiki H; Kontogianni M; Wolan M; Kikawa Y; Lanceley A; Gioulbasanis I; Harle A; Zarandona U; Kulis D; Kuljanic K;
    Health Qual Life Outcomes; 2024 Oct; 22(1):87. PubMed ID: 39385305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.